Your browser doesn't support javascript.
Remdesivir as a broad-spectrum antiviral drug against COVID-19.
Hong, Y-N; Xu, J; Sasa, G B K; Zhou, K-X; Ding, X-F.
  • Hong YN; Zhejiang Sci-Tech University, Zhejiang, HangZhou, China. bdd114@163.com.
Eur Rev Med Pharmacol Sci ; 25(1): 541-548, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1052581
ABSTRACT

OBJECTIVE:

List the clinical data of the role of remdesivir in COVID-19, and try to make an objective evaluation and analyze its feasibility. MATERIALS AND

METHODS:

The keywords of "remdesivir", "COVID-19" and "SARS-CoV-2" were systematically searched in PubMed and Web of Science. After removing the repetitions, we summarize articles, letters, and comments on remdesivir in the treatment of COVID-19.

RESULTS:

In this review, we summarize clinical case of using remdesivir in the treatment of COVID-19, analyzed the final treatment results, and judged whether the drug was effective for the treatment of COVID-19. Also, attention was paid to the side effects of the drug.

CONCLUSIONS:

According to the clinical results, it was found that remdesivir was effective in the treatment of COVID-19. The drug has side effects, but the symptoms were mild and disappeared immediately after discontinuation of medication.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Adenosine Monophosphate / Alanine / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Reviews Limits: Humans Language: English Journal: Eur Rev Med Pharmacol Sci Journal subject: Pharmacology / Toxicology Year: 2021 Document Type: Article Affiliation country: Eurrev_202101_24426

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Adenosine Monophosphate / Alanine / SARS-CoV-2 / COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study / Reviews Limits: Humans Language: English Journal: Eur Rev Med Pharmacol Sci Journal subject: Pharmacology / Toxicology Year: 2021 Document Type: Article Affiliation country: Eurrev_202101_24426